Researchers from Copenhagen and the US have succeeded in slowing the progression of Huntington’s disease in mice with a transplant of healthy human brain cells. This provides a new route to tackle this incurable fatal disease.
Cell therapies are promising for some of the most serious diseases, from their role in cancer treatment (one of the ways Biotech is curing cancer) to treat osteoporosis, tackle Crohn’s disease and solve diabetes.
Now, cell therapies are one step closer to the wall of fame in developments for major neurodegenerative diseases, by providing a way to slow down Huntington’s disease – a fatal disease so far with no therapy options.
This is where results from research groups at the University of Rochester (US) and the University of Copenhagen (Denmark) are pointing. They have now been published in the journal Nature Communications.
The researchers implanted healthy human glial cells in mice with Huntington’s disease –